For the Inventor, By the Inventor

Enter assignee name

Verdun, Quebec, undefined

Aegera Therapeutics, Inc.

USPTO Granted Patents = 24

% Expired Patents = 62.5

Forward Citations = 110

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Robert G Korneluk (10 out of 30 patents)

James B Jaquith (10 out of 21 patents)

Alain Boudreault (8 out of 15 patents)

4. Peter Liston (8 out of 15 patents)

5. Alexander E MacKenzie (7 out of 15 patents)

6. Stephen Baird (7 out of 14 patents)

7. Stephen J Morris (6 out of 12 patents)

8. Alain Laurent (6 out of 22 patents)

9. John W Gillard (6 out of 9 patents)

10. Jon P Durkin (6 out of 7 patents)

11. Eric LaCasse (4 out of 6 patents)

12. H Nicholas Marsh (3 out of 7 patents)

13. Patrick Bureau (3 out of 10 patents)

14. Daniel McManus (3 out of 4 patents)

15. Gerald Villeneuve (3 out of 3 patents)

24 patents: Sort by Forward Citations

1. 7795298 - IAP BIR domain binding compounds (2010-09-14),

2. 7772260 - [object Object] (2010-08-10),

3. 7772177 - BIR domain binding compounds (2010-08-10),

4. 7741349 - Imidazo[2, 1-b]-1,3,4-thiadiazole sulfonamides (2010-06-22),

5. 7714003 - [object Object] (2010-05-11),

6. 7700635 - [object Object] (2010-04-20),

7. 7645741 - IAP BIR domain binding compounds (2010-01-12),

8. 7638620 - Antisense IAP nucleobase oligomers and uses thereof (2009-12-29),

9. 7638497 - Antisense IAP nucleobase oligomers and uses thereof (2009-12-29),

10. 7589118 - IAP BIR domain binding compounds (2009-09-15),

11. 7579320 - IAP BIR domain binding compounds (2009-08-25),

12. 7294713 - Antisense IAP oligonucleotides and uses thereof (2007-11-13),

13. 7230019 - Imidazo [2,1-b]-1,3,4-thiadiazole sulfonamides (2007-06-12),

14. 7129250 - Neuroprotective and anti-proliferative compounds (2006-10-31),

15. 7091333 - Antisense IAP nucleobase oligomers and uses thereof (2006-08-15),

Aegera Therapeutics, Inc. is a biotechnology company based in Verdun, Quebec, specializing in the development of innovative therapies for cancer and other serious diseases. The company focuses on harnessing the power of small molecules to modulate cellular pathways, aiming to improve patient outcomes through targeted treatments. Aegera's research encompasses various aspects of drug discovery and development, positioning it at the forefront of therapeutic advancements in the life sciences sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

24 Patents

#1 in Verdun, Quebec

#603 in unknown

#26,595 in the World

Verdun, Quebec, undefined

Aegera Therapeutics, Inc.

Forward Citations = 110

31 inventors:

Robert G Korneluk (10 out of 30 patents)

James B Jaquith (10 out of 21 patents)

Alain Boudreault (8 out of 15 patents)

4. Peter Liston (8 out of 15 patents)

5. Alexander E MacKenzie (7 out of 15 patents)

Please report any incorrect information to [email protected]

Loading…